Single-cell analysis of Ki67+ and Ki67− cells of 7 progressively transformed germinal centers
Pt . | Cells . | Cells or samples positive in PCR (%)* . | Cells with mutated rearrangements/cells informative (%)† . | Cells belonging to clones . | No. clones (no. cells/clone) . | |
---|---|---|---|---|---|---|
Mutated . | Unmutated . | |||||
1 | Ki67+ | 15/80 (19) | 7/13 (54) | 0/15 | 0 | 0 |
Ki67−(3-4 cells/tube) | 21/60 (35) | 6/14 (43)‡ | 0/21 | 0 | 0 | |
2 | Ki67+ | 39/80 (49) | 13/31 (42) | 14/39 | 3 (7/2/2) | 2 (2/12-153) |
Ki67−(2-3 cells/tube) | 23/50 (46) | 6/23 (26)‡ | 3/23 | 0 | 2 (2/12-153) | |
3 | Ki67+ | 19/50 (38) | 9/13 (69) | 6/19 | 1 (6) | 0 |
Ki67− (2-3 cells/tube) | 24/55 (44) | 3/16 (19)‡ | 2/24 | 0 | 1 (2) | |
4 | Ki67+, PTGC1 | 22/60 (37) | 6/19 (32) | 6/22 | 1 (3) | 1 (3) |
Ki67+, PTGC2 | 25/80 (31) | 14/24 (58) | 7/25 | 2 (4/3) | 0 | |
5 | Ki67+, PTGC1 | 32/60 (53) | 27/29 (93) | 19/32 | 1 (19) | 0 |
Ki67+, PTGC2 | 30/60 (50) | 13/24 (54) | 10/30 | 2 (8/2) | 0 |
Pt . | Cells . | Cells or samples positive in PCR (%)* . | Cells with mutated rearrangements/cells informative (%)† . | Cells belonging to clones . | No. clones (no. cells/clone) . | |
---|---|---|---|---|---|---|
Mutated . | Unmutated . | |||||
1 | Ki67+ | 15/80 (19) | 7/13 (54) | 0/15 | 0 | 0 |
Ki67−(3-4 cells/tube) | 21/60 (35) | 6/14 (43)‡ | 0/21 | 0 | 0 | |
2 | Ki67+ | 39/80 (49) | 13/31 (42) | 14/39 | 3 (7/2/2) | 2 (2/12-153) |
Ki67−(2-3 cells/tube) | 23/50 (46) | 6/23 (26)‡ | 3/23 | 0 | 2 (2/12-153) | |
3 | Ki67+ | 19/50 (38) | 9/13 (69) | 6/19 | 1 (6) | 0 |
Ki67− (2-3 cells/tube) | 24/55 (44) | 3/16 (19)‡ | 2/24 | 0 | 1 (2) | |
4 | Ki67+, PTGC1 | 22/60 (37) | 6/19 (32) | 6/22 | 1 (3) | 1 (3) |
Ki67+, PTGC2 | 25/80 (31) | 14/24 (58) | 7/25 | 2 (4/3) | 0 | |
5 | Ki67+, PTGC1 | 32/60 (53) | 27/29 (93) | 19/32 | 1 (19) | 0 |
Ki67+, PTGC2 | 30/60 (50) | 13/24 (54) | 10/30 | 2 (8/2) | 0 |
In all patients, 45 to 56 buffer aliquots covering the Ki67-stained sections were taken as negative controls. In patient 2 the same VH 3-23 rearrangement was amplified from one cell and a buffer control. This cell was excluded from further analysis. In each of patients 4 and 5, a single unmutated VH rearrangement unrelated to the rearrangements amplified from micromanipulated cells was amplified. In addition, for all patients, 20 to 24 CD3+cells were micromanipulated from adjacent CD3-stained sections. Eight buffer aliquots taken from each of these sections were always negative. From one CD3+ cell of patient 3, an unmutated Vκ and a unmutated Vλ rearrangement were amplified.
All sequences have been deposited in the EMBL database under accession numbers AJ406595-925, AJ298845-863, and AJ299840-944.
Pt indicates patient, PCR, polymerase chain reaction; PTGC, progressively transformed germinal center.
PCR was performed for VH, Vκ, and Vλ gene rearrangements. Cells from which combinations of rearrangements indicative of cellular contamination were obtained (more than 2 rearrangements per locus or combinations of informative unmutated rearrangements with rearrangements mutated more than 5%) were excluded from further analysis (one Ki67+ cell of patient 2; 3 cells of PTGC1 of patient 5; one cell of PTGC2 of patient 5).
Cells from which only unmutated Vκ rearrangements were obtained are uninformative regarding somatic hypermutation.12 13
Patient 1: 6 of 18 informative rearrangements mutated, obtained from 6 of 14 informative samples. Patient 2: 7 of 40 informative rearrangements mutated, obtained from 6 of 23 informative samples. Patient 3: 3 of 21 informative rearrangements mutated, obtained from 3 of 16 informative samples.
From one Ki67+ cell and a Ki67− sample, the same unmutated and potentially functional Vλ 3h rearrangement with 2 N-nucleotides was amplified. These 2 cells likely represent members of a clone, though it cannot be excluded that the 2 cells are clonally unrelated.